Objective: The purpose of this study was to investigate the efficacy of 3.0T MR imaging in the assessment of depth of myometrial invasion by endometrial carcinoma. Methods: Fifty women with histopathologically confirmed endometrial carcinoma underwent preoperative MR imaging at 3.0T. MR imaging findings were compared with microscopic pathologic findings in all cases. On evaluation of MR images and histopathological findings, myometrial invasion was classified as absent (tumor confined to the endometrium), superficial (less than 50% of myometrial thickness), or deep (50% or more of myometrial thickness) by two radiologists. Results: The sensitivity, specificity, and accuracy of the MR imaging in distinguishing no myometrial invasion from myometrial invasion were 95/95, 60/70, and 88/90%, respectively, and no and superficial myometrial invasion from deep myometrial invasion were 88/94, 97/94, and 94/92%, respectively. Conclusions: In evaluation of the depth of myometrial invasion by endometrial carcinoma, 3.0T MR imaging has a high diagnostic accuracy that is equivalent to that of previously reported 1.5T MR imaging.
metastases are closely related to the prognosis, it is very important to evaluate myometrial invasion preoperatively [1] [2] [3] . The usefulness of magnetic resonance (MR) imaging in the preoperative assessment of the depth of myometrial invasion of endometrial carcinoma has been recognized [4] [5] [6] [7] [8] . It has been shown to have higher accuracy than other imaging modalities, such as ultrasonography and computed tomography [9, 10] . Furthermore, MR imaging correctly differentiates the presence of deep myometrial invasion from more superficial involvement [11] [12] [13] [14] .
Recently, MR imaging with field strengths of 3.0T has rapidly become clinically available in the body in addition to the brain. In general, 3.0T MR imaging offers a higher signal-to-noise ratio (SNR) and higher spectral separation than 1.5T MR imaging. The gain in SNR can be maintained or traded for imaging speed and/or spatial resolution. Compared to 1.5T, potential outcomes of 3.0T imaging include changes in tissue T1 and T2 relaxation times, increased magnetic susceptibility effects, and increased power deposition [15] . Although 3.0T imaging has been shown to be more effective than 1.5T imaging for the brain and musculoskeletal system, its advantages are controversial in the chest, abdomen, and pelvis because of artifacts such as greater magnetic susceptibility, the dielectric effect, and field inhomogeneity caused by reduced radiofrequency penetration power [16] [17] [18] [19] .
In imaging of the female pelvis, some studies have reported the effect of these artifacts on image quality. Hori et al. [20] reported that image homogeneity of T2-weighted and dynamic MR images at 3.0T is inferior to that the homogeneity at 1.5T. Magnetic susceptibility artifacts are theoretically expected to double at 3.0T compared to 1.5T [19, 21] . However, susceptibility artifacts did not affect diagnostic accuracy in the pelvis, because these artifacts do not reach the uterus [22] . Dielectric artifacts can be improved by placing dielectric pads on the anterior abdominal wall [18, 23] . Kataoka et al. [24] demonstrated that dielectric pads improve image inhomogeneity of the female pelvis at 3.0T.
Meanwhile, some reports have investigated the value of 3.0T MR imaging for examination of gynecologic diseases [20, 22, 25] , and two studies reported the feasibility of 3.0T MR imaging for the preoperative evaluation of myometrial invasion in endometrial carcinoma [20, 22] . However, investigations into the efficacy of 3.0T MR imaging for evaluation of myometrial invasion by endometrial carcinoma are not yet sufficient. Therefore, in this study, the efficacy of 3.0T MR imaging for assessment of myometrial invasion by endometrial carcinoma was investigated.
Materials and methods

Patients
This study evaluated 55 consecutive patients with endometrial adenocarcinoma diagnosed by endometrial biopsy. However, four patients were excluded because the definitive histopathology was not adenocarcinoma (three were carcinosarcoma and one was metastatic tumor from ovarian carcinoma). Only patients with an interval of less than 2 months between MR imaging examinations and laparotomy were included. For this reason, one patient was excluded because this interval was longer than 2 months. Finally, the population enrolled was 50 patients. The patients were 32-86 years old (mean 61 years). Nine patients were premenopausal and 41 patients were postmenopausal. Five patients were receiving hormone replacement therapy. All patients underwent hysterectomy with bilateral salpingo-oophorectomy, with sampling or total resection of pelvic and paraaortic lymph nodes. All of the patients underwent surgery 1-55 days after MR examination (mean time 24 days), and macroscopic and microscopic specimens were obtained.
MR examination
MR imaging was performed with a 3.0T MR system (Signa EXCITE HD; GE Medical Systems Milwaukee, WI, USA) with an 8-channel cardiac coil. A dielectric pad was placed on the patient's body in order to improve the image homogeneity. After acquisition of localization images, T2-weighted fast spin-echo images were obtained in parasagittal planes parallel to the longitudinal axis of the uterus, and in oblique axial planes taken in a direction parallel to the short axis. The imaging parameters were as follows: repetition time (TR)/echo time (TE) of 6500/100 ms for parasagittal planes and oblique axial planes, the matrix size was 512 9 384, and the section thickness was 5 mm in the parasagittal planes and 3 mm in the oblique axial planes. The intersection gap was 1.5 mm in the parasagittal planes and 0.9 mm in the oblique axial planes with 25-cm field of view. After obtaining T2-weighted images, precontrast T1-weighted and contrast-enhanced dynamic MR images were obtained in parasagittal planes. Dynamic contrastenhanced images were obtained using T1-weighted 3D gradient echo (LAVA: Liver Acquisition of Volume Acceleration, GE Healthcare) with fat suppression sequences (TR/TE: 4/2 ms, 15°flip angle, 320 9 256 matrix, 1.6-mm section thickness, field of view 25 cm, receiver bandwidth ± 83.3 kHz, and one signal acquired). This sequence was used for a dynamic contrast-enhanced study for which images were acquired at four different phases relative to the injection of contrast agent (0.2 ml/kg of gadoterate dimeglumine at rate of 2.5 ml/s): basal (before gadolinium injection), early phase (30-60 s after starting the injection), venous phase (90 s after starting the injection) and delayed phase (120 s after starting the injection). Then, oblique axial plane images (3-mm section thickness, 0.9-mm intersection gap) were reconstructed using a workstation (Advantage Windows; General Electric, Milwaukee, WI, USA).
Before the MR examination, all patients received intramuscular administration of 20 mg of butyl-scopolamine (Buscopan; Nippon Boehringer Ingelheim, Tokyo, Japan) to prevent peristalsis artifacts except when contraindicated.
Image analysis
Two radiologists (with 12 and 3 years' experience in gynecological MR imaging) independently assessed the depth of myometrial invasion by evaluating both the T2-weighted (parasagittal and oblique axial) and the contrast-enhanced T1-weighted (parasagittal and oblique axial) images without knowledge of the final histologic results.
The assessments of myometrial invasion were made on the basis of established MR criteria. Myometrial invasion was categorized into three levels: (1) no invasion when a clear junctional zone (JZ) could be identified in T2-weighted images and when subendometrial enhancement (SEE) was smooth and clear on dynamic contrast-enhanced images (Fig. 1) ; (2) invasion of less than one-half the myometrium when a partially ruptured JZ was identified or when SEE was irregular, with tumor signals remaining in one-half of the myometrium (Fig. 2) ; and (3) invasion of equal to or more than one-half the myometrium when a partially interrupted JZ was identified or when SEE was irregular, with tumor signals in equal to or more than one-half the myometrium (Fig. 3) [26] .
Histopathologic analysis
Surgical specimens were sectioned along the longitudinal plane of the uterus. After the depth of myometrial invasion was estimated grossly, it was confirmed microscopically without knowledge of the MR findings, and was classified as tumor confined to the endometrium, tumor infiltrating less than 50% of myometrial thickness, or tumor infiltrating 50% or more of myometrial thickness by an experienced pathologist.
Statistical analysis
Reader interpretations of MR images were compared with the histopathological findings. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy were calculated.
Interobserver agreement between the two observers was determined by calculating the weighted j values, with a j value of 0.00 indicating poor agreement; 0.01-0.20, slight agreement; 0.21-0.40, fair agreement; 0.41-0.60, moderate agreement; 0.61-0.80, good agreement; and 0.81-1.00, excellent agreement.
Results
Fifty patients with endometrial carcinoma were evaluated by pathologic specimens. A total of 20% (n = 10) of cases had no myometrial involvement. Superficial myometrial involvement was observed in 48% (n = 24), and deep myometrial involvement was observed 32% (n = 16) cases.
Concerning histologically observed differentiation between no myometrial invasion and myometrial invasion and the radiologists' interpretations, reader 1 overestimated four cases and underestimated two cases, and reader 2 overestimated three cases and underestimated two cases. Both readers overestimated five cases and underestimated three cases (Table 1) . Regarding overestimated cases, in one case with a large polypoid tumor and one case with intramuscular leiomyoma, dynamic contrast-enhanced images showed that the SEE line was irregular. Two other cases and the case with intramuscular leiomyoma underwent endometrium curettage. In another case with leiomyoma, evaluation by dynamic contrast-enhanced imaging was difficult because SEE was not identified. Regarding underestimated cases, slight myometrial invasion was identified at histopathologic evaluation. In one underestimated case, evaluation by dynamic contrast-enhanced imaging was difficult because SEE was not identified.
For the diagnosis of deep myometrial invasion, reader 1 overestimated one case and underestimated two cases, Junctional zone is not visible. Parasagittal (C) and oblique axial (D) dynamic contrast-enhanced images in the late phase clearly demonstrate that hypointense tumor has invaded more than 50% of the myometrium (arrowheads). and reader 2 overestimated three cases and underestimated one case. Both readers overestimated three cases and underestimated three cases ( Table 2) . One of the three overestimated cases had a large tumor. In the remaining two cases, the cause was not clear. Regarding underestimated cases, one case was just more than onehalf myometrial invasion at histopathologic evaluation. In the remaining two cases, there was marked distention of the endometrial cavity by hydrometra or large tumor. The sensitivity, specificity, accuracy, PPV, and NPV values assessed by each reader for distinguishing no myometrial invasion from myometrial invasion and superficial from deep myometrial invasion are shown in Tables 3 and 4 . In this study, j statistics indicated a good degree of agreement between the two observers (j = 0.67).
Discussion
These results demonstrated that the sensitivity, specificity, and diagnostic accuracy for the absence of myometrial invasion were 95, 60-70, and 88-90%, respectively. These results showed that the sensitivity was similar to that of previous studies and the specificity was similar or slightly lower than those of previous studies using 1.5T MR imaging [11, [27] [28] [29] . Presurgical knowledge of the absence of myometrial invasion is very important because patients who still want to preserve their childbearing ability may be able to choose hormone therapy when there is no myometrial invasion present [30] . SEE is a useful criterion for evaluation of myometrial invasion. SEE has been reported to be observed between the endometrium and myometrium [27] . SEE is frequently observed in postmenopausal patients and premenopausal women during the proliferative phase [27] . The disruption of SEE was interpreted as myometrial invasion.
However, the assessment of SEE is sometimes difficult in patients with endometrial cavity distention with polypoid tumors or intramuscular leiomyoma [31, 32] and in premenopausal women except for during the proliferative phase of the menstrual cycle [27] .
In cases in which SEE cannot be identified, myometrial invasion is generally evaluated only by T2-weighted images. Previous reports using 1.5T imaging demonstrate that poor contrast between the tumor and the myometrium on T2-weighted images sometimes made it difficult to evaluate myometrial invasion accurately [6, 27, 33] . A recent report demonstrated that the image contrast in the uterine zonal appearance on T2-weighted fast spin-echo imaging has no significant difference between 3.0T and 1.5T in subjects without administration of antiperistaltic agents [34] , although motion artifacts such as uterine peristalsis and contraction can be reduced by antiperistaltic agents. A recent report showed that there are no significant differences between 3.0T and 1.5T in tumorto-junctional zone contrast-to-noise ratio on T2-weighted images [20] . Therefore, it may be difficult to diagnose myometrial invasion more correctly with 3.0T imaging in cases evaluated by T2-weighted images alone.
In overestimated cases in which SEE was identified, the SEE line was irregular. For this reason, in addition to endometrial cavity distention of polypoid tumor or intramuscular leiomyoma [31, 32] , uterine curettage may be considered. A previous report demonstrated that uterine changes after uncomplicated uterine curettage were confined to the endometrium and the junctional zone remained intact on T2-weighted images [35] . Meanwhile, another previous report indicated that the appearance of the endometrial-myometrial interface may have been changed by uterine curettage [36] . To the knowledge, there have been no studies that have investigated changes in the appearance of the uterus on dynamic contrast-enhanced MR images after uterine curettage; the effect of uterine curettage on SEE is not sufficient to survey. Although further examination is needed for confirmation of this observation, uterine curettage may sometimes affect visualization of SEE and degrade the diagnostic accuracy of myometrial invasion.
In underestimated cases, microscopic myometrial invasion was not detectable on MR images. In general, 3.0T MR imaging has higher spatial resolution compared to lower field strengths due to high SNR. The contrast enhancement effect of gadolinium agents is theoretically higher at 3.0T than at 1.5T due to longer baseline relaxation times at 3.0T that yield a stronger T1 reduction [21] . This has been demonstrated in vivo for imaging brain tumors [37] . However, in breast MR imaging, a recent report demonstrated that 1.5T imaging had stronger contrast enhancement for breast tumors compared to 3.0T imaging [38] . In female pelvic imaging, another recent report showed that there were no significant differences between 3.0T and 1.5T MR imaging in image quality or in enhancement rate of the myometrium on contrast-enhanced T1-weighted images [20] . Therefore, it remains controversial whether contrast-enhanced pelvic imaging at 3.0T is superior to that at 1.5T. As suggested by the results of this study, microscopic myometrial invasion may not be detectable even by dynamic contrast-enhanced imaging at 3.0T; this may be a limitation of MR imaging. The depth of myometrial invasion of endometrial carcinoma has been shown to be directly related to prognosis, length of time until recurrence, and the presence of pelvic and paraaortic lymph node metastases [39] [40] [41] [42] [43] . Therefore, accurate evaluation is mandatory for preoperative planning of the extent of lymphadenectomy in addition to hysterectomy and bilateral salpingooophorectomy. Regarding deep myometrial invasion, these results demonstrated that the sensitivity, specificity, and diagnostic accuracy for the presence of deep myometrial invasion were 88-94, 94-97, and 92-94%, respectively. These results are similar to those of previous studies using 1.5T imaging [29, 44] and 3.0T imaging [22] . In general, dynamic contrast-enhanced MR imaging is useful for evaluating myometrial invasion [11, 14, 27, 45] , particularly when the JZ is poorly visible on T2-weighted images, because endometrial carcinoma is usually less enhanced than the adjacent myometrium during the venous and delayed phase [5, 27, 35] . Therefore, in this study, the depth of myometrial invasion was evaluated with both T2-weighted imaging and dynamic contrastenhanced MR imaging. As described above, there were no significant differences between 3.0T and 1.5T imaging in image quality or in enhancement rate of the myometrium on contrast-enhanced T1-weighted images [20] . Therefore, we consider that the result at 3.0T is similar to those of previous studies using 1.5T imaging. Meanwhile, in the cases in this report, half of the cases inaccurately diagnosed by MR imaging showed diminishing myometrial thickness because of distention of the endometrial cavity by hydrometra or large tumor. This condition of diminishing myometrial thickness tends to make it difficult to assess the degree of tumor invasion with MR imaging [36, 45] , regardless of field strength. For these reasons, these results are not clearly superior to those of previous reports using 1.5T in the evaluation of myometrial invasion.
Some limitations of this study need to be taken into consideration. First, this was a retrospective study, and the readers knew the diagnosis of endometrial carcinoma when they reviewed the images, which may have influenced the readers. Second, the study was also limited by the relatively small number of patients included. Large sample sizes are needed to evaluate the diagnostic performance with greater precision. Third, dynamic contrast-enhanced MR imaging was obtained using LAVA. LAVA is a dynamic contrast-enhanced MR imaging sequence designed for the abdomen, not for the pelvis. Therefore, there was a possibility that better imaging quality and higher diagnostic performance could be obtained by further adjustment of operating parameters and/or optimization of the pulse sequence specifically for imaging the female pelvis.
In conclusion, 3.0T MR imaging has a high diagnostic accuracy, which is equivalent to that of previously reported 1.5T MR imaging, in the evaluation of the depth of myometrial invasion by endometrial carcinoma.
